DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Alphabody
Alphabody
Protein Conjugation with Triazolinediones: Switching from a General Tyrosine-Selective Labeling Method to a Highly Specific Tryptophan Bioconjugation Strategy Klaas W
International Patent Classification: KR, KW, KZ, LA, LC, LK, LR, LS, LU
The Organizing Committee Gratefully Acknowledges the Symposium
THE ESSENTIAL PROTEIN ENGINEERING SUMMIT May 1-5
WO 2019/046815 Al 07 March 2019 (07.03.2019) W 1P O PCT
WO 2017/147538 Al 31 August 2017 (31.08.2017) P O P C T
Weight Change
Supporting Information
Suderman Et Al. 2017
Structural Basis of IL-23 Antagonism by an Alphabody Protein Scaffold
Press Release Complix Extends Series a Financing to EUR 7 Million With
Non-Immunoglobulin Scaffold Proteins: Precision Tools for Studying Protein-Protein Interactions in Cancer
Novel Functional Strategy for Development of Highly Specific Antibody Drug Conjugates for Non-Hodgkin's Lymphoma
Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
Development of Nanobodies to Image Synaptic Proteins in Super-Resolution Microscopy’ Independently and with No Other Aid Or Sources Than Quoted
Partnering Forum PARTNERING FORUMS Emerging Antibody & Protein Engineering
Engineering a 45-Amino Acid Protein Scaffold for Molecular Cancer Imaging
Affitin-Dendrimer Conjugates for Multivalency-Enhanced Targeting »
Top View
Ep 2800759 B1
A New Technology for Targeting Proteins Inside Cells
Plenary Keynotes
Developing Receptor-Directed Synthetic Antagonists Against the IL-23 Signal Transduction Pathway
Valentina KALICHUK
GC MD THESIS Corrected 20.9.20.Pdf
Pathophysiology and Inhibition of IL-23 Signaling in Psoriatic Arthritis
WO 2018/056821 Al 29 March 2018 (29.03.2018) W !P O PCT
Designing Helical Peptide Inhibitors of Protein-Protein Interactions
Challenges and Opportunities for Non-Antibody Scaffold Drugs